« FDA Approvals - FDA Calendar, Unbiased Reporting on Emerging Biotech Sector Now Available | Main | FDA Warns Against Consuming Peanuts and Peanut Products Sold by »

Antares Pharma Announces Going Concern Qualification (Business Wire via Yahoo!


Antares Pharma Announces Going Concern Qualification (Business Wire via Yahoo! Finance)
EWING, N.J.----Antares Pharma, Inc. today announced that its audited financial statements for the fiscal year ended December 31, 2008, included in the Company's Annual Report on Form 10-K, filed on March 25, 2009, contained a going concern qualification from its independent registered accounting firm, KPMG LLP.

Somaxon Receives Notice of Non-Compliance with Nasdaq Continued Listing Requirements (Business Wire via Yahoo! Finance)
SAN DIEGO----Somaxon Pharmaceuticals, Inc. , a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced that on March 20, 2009 it received a letter from the Listing Qualifications Department of the Nasdaq ...

FDA Fireside Chat @ The 8th Annual MedTech Investing Conference May 6-7, 2009 (PR Newswire via Yahoo! Finance)
Billion Dollar Medical Device Market
 

©2006 FDA-News.com. All rights reserved.